Paul Chaplin

Chief Executive Officer en BAVARIAN NORDIC A/S .

57 años

Health Technology

Commercial Services

Consumer Services

Perfil

Paul Chaplin is currently the President & Chief Executive Officer at Bavarian.
Nordic A.
He is also the President at Bavarian Nordic, Inc. Additionally, he serves as the General Manager at Bavarian Nordic GmbH.
Dr. Chaplin holds a doctorate degree from the University of Bristol.

Cargos activos de Paul Chaplin

Empresas	Cargo	Inicio
BAVARIAN NORDIC A/S	Chief Executive Officer	28/05/2014
Bavarian Nordic GmbH Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999.	Corporate Officer/Principal	03/03/2011
Bavarian Nordic, Inc. Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC.	President	-

Todos los cargos activos de Paul Chaplin

Formación de Paul Chaplin.

University of Bristol

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Paul Chaplin.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
BAVARIAN NORDIC A/S	Health Technology

Empresas privadas	2
Bavarian Nordic, Inc. Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC.	Commercial Services
Bavarian Nordic GmbH Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999.	Health Technology

Ver las conexiones de la empresa